Eye implant may be used to treat diabetes
Researchers in Sweden have developed a microscale device for implantation in the eye, which presents new opportunities for cell-based treatment of diabetes and other diseases.
Aiming to encapsulate insulin-producing pancreatic cells and electronic sensors, the 3D-printed device was developed by a team from KTH Royal Institute of Technology and Karolinska Institutet. The researchers reported the results of the work in the journal Advanced Materials.
The collaboration between KTH and Karolinska Institutet enables micro-organs—namely pancreatic islets or islets of Langerhans—to be positioned precisely in the eye without need for sutures. It offers the possibility of cell-based therapy, for example to treat Type 1 or Type 2 diabetes, using the eye as a base.
Anna Herland, senior lecturer in the Division of Bionanotechnology at SciLifeLab at KTH and the AIMES research center at KTH and Karolinska Institutet, says that the eye is ideal for this technology because it has no immune cells that react unfavorably in the first stage of implantation. Its transparency allows visual and microscopic study of what happens to the implant over time.
“The eye is our only window into the body, and it’s immune-privileged,” Herland says.
The device is designed as a wedge, about 240 micrometers long, allowing the structure to be mechanically fixed at the angle between the iris and the cornea in the anterior chamber of the eye (ACE). The work demonstrates the first mechanical fixation of a device in the anterior chamber of the eye.
“We designed the medical device to hold living mini-organs in a micro-cage and introduced the use of a flap door technique to avoid the need for additional fixation,” says Wouter van der Wijngaart, professor in the Division of Micro- and Nanosystems at KTH.
In tests on mice the device maintained its position in the living organism for several months, and the mini-organs quickly integrated with the host animal's blood vessels and functioned normally, Herland says.
Per-Olof Berggren, professor of experimental endocrinology at Karolinska Institutet contributed to the research with years of experience in transplanting islets of Langerhans to the anterior chamber of the eye in mice.
“The current unit is unique and will among other things form the basis for our continued work to develop an integrated microsystem for studying the function and survival of the islets of Langerhans in the anterior chamber of the eye,” Berggren says. “This is also of great translational importance, as transplantation of Langerhans islands to the anterior chamber of the eye in humans is subject to clinical trials in patients with diabetes."
Herland says the technology overcomes one obstacle to the development of cell therapies, including those for diabetes. Namely, there is no need for invasive methods to monitor the graft’s function and to guide care in order to ensure long-term transplant success.
“Ours is a first step towards advanced medical microdevices that can both localize and monitor the function of cell grafts,” she says.
She says the design makes it possible to position mini-organs such as organoids and islets of Langerhans without limiting the supply of nutrients to the cells.
“Our design will enable future integration and use of more advanced device functions such as integrated electronics or drug release."
The research has been funded by SSF, Knut and Alice Wallenberg Foundation, ERC, Erling Persson Family Foundation and Jochnick Foundation, AIMES and Novo Nordisk Foundation.
The study’s conflict of interest statement notes that Per-Olof Berggren is a partner in Biocrine AB, which is also part of the study.
Images
Links
Subscribe to releases from KTH Royal Institute of Technology
Subscribe to all the latest releases from KTH Royal Institute of Technology by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from KTH Royal Institute of Technology
1,000 times smaller than a grain of sand—glass sensors 3D-printed on optical fiber15.5.2024 15:06:46 CEST | Press release
In a first for communications, researchers in Sweden 3D printed silica glass micro-optics on the tips of optic fibers—surfaces as small as the cross section of a human hair. The advance could enable faster internet and improved connectivity, as well as innovations like smaller sensors and imaging systems.
Climate is one culprit in spread and growth of Middle East dust levels30.4.2024 08:49:52 CEST | Press release
Climate change is transforming dust storms—a natural phenomenon in the Middle East—into a more frequent and widespread threat to health and economies throughout the region, a new study shows.
Device improves stem cell generation and chance for accessible Alzheimer’s cell therapy24.4.2024 20:18:16 CEST | Press release
Researchers in Sweden say they have improved on a technique for converting regular skin cells into neural stem cells—an advance which they say helps close the gap for accessible personalized cell-based therapies for Alzheimer's and Parkinson's.
Global warming and plastic pollution entwined in vicious circle, report says19.3.2024 10:56:01 CET | Pressmeddelande
Typically viewed as unrelated problems, global warming and plastic pollution are instead inextricably trapped in a “vicious circle” where one feeds the other, researchers in Sweden report in Nature Communications. The mutually-reinforcing relationship escalates global warming, the degradation of materials, plastic waste and the leaching of toxic chemicals into the biosphere.
New hydrogen producing method is simpler and safer7.3.2024 13:57:26 CET | Press release
Researchers in Sweden unveiled a new concept for producing hydrogen energy more efficiently, splitting water into oxygen and hydrogen without the dangerous risk of mixing the two gases.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom